Skip to main content

Table 2 The number of DS-DMRs in different tissues

From: Genome-wide survey reveals dynamic widespread tissue-specific changes in DNA methylation during development

 

Total

Adjusted#

%1

CpGi-Prom

%2

non-CpGi-Prom

%2

Intra-genic CpGi

%2

Inter-genic CpGi

%2

Brain:

Common

1903

NA

ND

182

9.6

1018

53.5

493

25.9

210

11.0

E15_uniq

533

533

27.5

105

19.7

359

67.4

35

6.6

34

6.4

E15+NB

490

509

25.3

66

13.5

368

75.1

29

5.9

27

5.5

NB_uniq

370

400

19.1

55

14.9

248

67.0

42

11.4

25

6.8

AD_uniq

408

532

21.1

94

23.0

233

57.1

52

12.7

29

7.1

NB+AD

70

82

3.6

5

7.1

40

57.1

16

22.9

9

12.9

E15+AD

65

77

3.4

11

16.9

46

70.8

7

10.8

1

1.5

Total*

1936

2132

100.0

336

15.2

1294

62.6

181

13.9

125

8.4

UnMe-AD**

1393

1442

72.0

226

16.2

975

70.0

106

7.6

86

6.2

Me-AD***

543

691

28.0

110

20.3

319

58.8

75

13.8

39

7.2

Heart:

Common

1844

NA

ND

218

11.8

946

51.3

491

26.6

189

10.2

E15_uniq

46

81

6.9

27

58.7

8

17.4

2

4.3

9

19.6

E15+NB

87

125

13.0

17

19.5

61

70.1

4

4.6

5

5.7

NB_uniq

93

112

13.9

12

12.9

64

68.8

7

7.5

10

10.8

AD_uniq

172

172

25.6

45

26.2

83

48.3

33

19.2

11

6.4

NB+AD

246

253

36.7

44

17.9

132

53.7

54

22.0

16

6.5

E15+AD

27

34

4.0

6

22.2

15

55.6

5

18.5

1

3.7

Total*

671

777

100.0

151

22.4

363

54.1

105

15.6

52

7.7

UnMe-AD**

226

318

33.7

56

24.8

133

58.8

13

5.8

24

10.6

Me-AD***

445

459

66.3

95

21.3

230

51.7

92

20.7

28

6.3

Liver:

Common

1497

NA

ND

141

9.4

726

48.5

425

28.4

205

13.7

E15_uniq

117

119

4.9

25

21.4

74

63.2

10

8.5

8

6.8

E15+NB

1419

1431

60.0

198

14.0

1034

72.9

125

8.8

62

4.4

NB_uniq

147

147

6.2

24

16.3

109

74.1

8

5.4

6

4.1

AD_uniq

468

813

19.7

70

15.0

322

68.8

45

9.6

31

6.6

NB+AD

36

46

1.5

2

5.6

30

83.3

3

8.3

1

2.8

E15+AD

194

249

8.1

13

6.7

130

67.0

31

16.0

20

10.3

Total*

2381

2804

100.0

332

13.9

1699

71.4

222

9.3

128

5.4

UnMe-AD**

1683

1696

70.7

247

14.7

1217

72.3

143

8.5

76

4.5

Me AD***

698

1107

29.3

85

12.

482

69.1

79

11.3

52

7.4

Testis:

           

Common

570

NA

ND

20

3.5

363

63.7

148

26.0

39

6.8

E15_uniq

272

380

6.3

105

38.6

101

37.1

33

12.1

33

12.1

E15+NB

939

1094

22.0

193

20.6

480

51.1

157

16.7

109

11.6

NB_uniq

798

789

18.4

231

28.9

391

49.0

86

10.8

90

11.3

AD_uniq

2214

2336

50.9

71

3.2

1908

86.2

165

7.5

70

3.2

NB+AD

63

65

1.4

3

4.8

48

76.2

9

14.3

3

4.8

E15+AD

62

91

1.4

5

8.1

38

61.3

14

22.6

5

8.1

Total

4348

4755

100.0

608

14.0

2966

68.2

464

10.7

310

7.1

UnMe-AD**

2009

2263

40.8

529

26.3

972

48.4

276

13.7

232

11.5

Me-AD***

2339

2493

47.6

79

3.4

1994

85.3

188

8.0

78

3.3

Grand Total:

Common

5814

NA

ND

561

9.6

3053

52.5

1557

26.8

643

11.1

DS-DMRs

9336

10469

100.0

1427

15.3

6322

67.7

972

10.4

615

6.6

UnMe-AD**

5311

5719

56.9

1058

19.9

3297

62.1

538

10.1

418

7.9

Me-AD***

4025

4750

43.1

369

9.2

3025

75.2

434

10.8

197

4.9

  1. %1: percentage is based on the row total vs. total DMRs; %2: percentage is based on the total of DMRs in the row; Total*: Stage specific; UnMe-AD**: unmethylated in AD but methylated in E15 and/or NB; Me-AD***: methylated in Adult but unmethylated in E15 and/or NB; Adjusted#: number of DMRs adjusted based on the adjusted coefficiency between the duplicated samples.